The Utility of feNO in the Differential Diagnosis of Chronic Cough

NCT02479074 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

49

Enrollment

OTHER_GOV

Sponsor class

Conditions

Cough

Interventions

DRUG: Montelukast (High FeNO group)
DRUG: Prednisolon, Montelukast (High FeNO)
DRUG: Montelukast (Low FeNO group)

Sponsor

Hull University Teaching Hospitals NHS Trust

Collaborators

[object Object]